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Convection-enhanced delivery (CED) is a proven method for targeted drug delivery
to the brain that circumvents the blood-brain barrier (BBB). Little study has been
conducted in understanding CED in pathological brain states. This is of importance when
dealing with chemotherapeutic agent delivery to brain tumors, where vasogenic edema
(VE) exists. The current study aims to characterize a model of VE suitable for studying
CED.
VE was produced in the right hemisphere of the rat brain using multiple infusions
of hyperosmotic mannitol(0.25mL/kg/s over 30 seconds) delivered through the right

...
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internal carotid artery. Magnetic resonance imaging (MRI) revealed consistent edema
formation and high water levels in the ipsilateral gray and white matter within an hour of
the first infusion. Evan's Blue (EB) staining verified that VE has formed. However,
apparent diffusion coefficient (ADC) and histological examination revealed also that some
possible cytotoxic edema formed.
This model provides a reproducible technique for generating a large area of edema
for CED study. Further studies with lower doses of mannitol, while titrating to changes in
ADC and values for fractional water content, may modify this model with a greater
component of VE and less cerebral toxicity.

CHAPTER 1

PATHOLOGICAL BRAIN STATES AND CONVECTION-ENHANCED
DELIVERY
For a variety of pathological brain states, such as traumatic brain injury (TBI),
ischemic stroke and tumors, systemic delivery of therapeutic agents to the brain is a
problem due to the blood-brain barrier (BBB).' Techniques such as convection-enhanced
delivery (CED) can by-pass the BBB, however the above conditions involve a significant
element of edema formation2 that can affect accurate dosing via C E D . ~
TBI, stroke and tumors generally have two types of edema associated with them:
cytotoxic edema (CE) and vasogenic edema (vE).~-' CE develops when cells of the brain
lack an energy supply and suffer from a breakdown of ion-transport. The increased levels
of intracellular sodium lead to increased water content and subsequent cellular s ~ e l l i n ~ . ~ ' ' ~
The intracellular swelling causes the extracellular space (ECS) to contract when compared
to normal brain. VE develops as a result of BBB breakdown and a build-up of water in the
ECS, and can be characterized by ECS expansion. Diagrams outlining the ECS changes
in both VE and CE are shown in Figure 1-1.

Figure 1-1. Diagram illustrating extracellular space morphology under conditions of
vasogenic and cytotoxic edema. A: Normal brain tissue. B: Vasogenic edema exhibits
extracellular space expansion. C: Cytotoxic edema is characterized by shrinkage of the
extracellular space. The intracellular spaces are shaded for clarity. (Diagrams courtesy of
P. ~ a a r ~ )
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Cytotoxic Edema
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Studies have found that TBI has an acute VE development, with .the BBB opening and
closing within 30 minutes of injury.' Increased apparent diffusion coefficient (ADC)
values obtained from magnetic resonance imaging (MRI) are sensitive to water protons in
the ECS. Elevated ADC values, consistent with VE, were found up to a period of 45
minutes post-injury in rats, however these values fell to below normal values and remained
low for weeks afterward, consistent with predominantly CE in this phase after
Therefore, the e d e ~ seen
a in TBI is mostly CE in nature. In ischemic brain injury, there is
acute CE developnlent from cellular damage followed by some mixture of VE
development several hours post-injury.6;'2 Tumors generally exhibit a high degree of VE in
the peritumoral t i s ~ u eSome
. ~ CE may be present due to ischemic anoxia in rapidly
growing tumors where vasculature does not keep up with the

cell^.'^"^ specific

mechanisms behind VE formation will be discussed in the next chapter.
A common and devastating form of brain tumor is glioblastoma multiforme
(GBM), which accounts for 50% of adult gliomas.'5 GBM is classified by the World
Health Organization (WHO) as a grade IV astrocytoma,I6 and is seen in 9,000 U.S. cases
annually with an incidence of 3 per 100,000 per year.'5 The highest incidence of GBM
occurs in the elderly and white males.17 Even with the combination of surgery,
chemotherapy, and radiation, the average survival time for patients is less than 2 years.'8
GBM is seen in two forms: (1) a primary form which develops directly from glial
cells, and (2) a secondary form which is thought to develop form from low-grade
astrocytomas that are already present in tissue.17The primary form is more aggressive and
invasive and is seen in an older population of individuals (median age = 62.2 years), while

the secondary form tends to arise in relatively younger patients (median age = 44.9
years).16'19
Regardless of pathway, the clinical signs of GBM remain the same: rapid
proliferation, diffuse invasion, angiogenesis, and tissue necrosis.16 Surrounding the tissue
is a region of peritumoral edema (PTE) which is VE in nature due to disruption of the BBB
in surrounding vasculature, and results in widening of the ECS,

the mechanism of

which is discussed in a later chapter. GBM cannot be cured by surgery but surgical
removal is the primary goal with such a high grade tumor, which is then followed by a
combination of radiotherapy and chemotherapy.15
Chemotherapeutic treatment of brain tumors is challenging via normal vascular
drug delivery due to the BBB.~'The normal BBB functions by preventing passage of water
soluble drugs that have a molecular weight greater than 180, whereas most
chemotherapeutic agents that are currently being used have a molecular weight between
200 and 1200.~'Lipid solubility, charge, and molecular mass are the most important
factors that determine if a drug can cross the BBB.~'By circumventing the BBB, CED is
an effective approach to targeted delivery of chemotherapeutic agents.1;22;23 CED involves
a catheter being placed directly into parenchymal tissue and the desired therapeutic agent is
slowly infused into the region via a pump mechanism (Figure 1-2 A). CED of toxins has
been used to treat gliomas.15;24
1n addition, CED of chemotherapeutics such as ~ a x oand
l ~ ~
liposomes' has been used.
CED should not be confused with direct stereotactic inoculation. The latter
technique creates a limited volume of distribution in the brain tissue (Vt) and therefore
reduces the agent's therapeutic utility.21The V, of the drug can be increased via fluid
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convection under a constant pressure gradient.2''26 Thus, the drug distribution relies on
the bulk flow of the fluid within the ECS of the brain. Bobo et al. found that by using a
bulk-flow technique, they could infuse ['"c]

sucrose (M,, 359) and ll'ln-labeled transferrin

(M,, 80,000) into the internal capsule of cats under low but constant pressure.27They
demonstrated a linear increase in Vt that correlated with volume of infusion. CED is
promising for clinical use, and can help circumvent the problem of poor drug delivery
when studying other chemotherapeutic agents derived from growth factors, genetic vectors,
enzymes, neurotrophic factors, and a n t i b ~ d i e sIn
. ~addition
~
to agents mentioned above,
CED has been used to deliver antisense oligonucleotides.28-30 CED is also applicable in
treating Parkinson's disease and other diseases associated with local or regional brain
abnormalities.

1;21:22:3 1

Since agents delivered to the brain via CED will distribute through the ECS,
pathological states affecting the ECS will directly affect drug distribution. As mentioned
above, peritumoral tissue exhibits VE and some C E . ' ~ ' ~Therefore,
'
understanding CED
distribution under pathological condition of VE is vital for accurate drug dosing and
delivery. The behavior of infusate under conditions of CE has been well characterized in
studies conducted by Haar, however the same studies showed inconclusive results for CED
in a model of VE utilizing prior direct intraparenchymal infusion of a l b ~ m i n . ~
VE leads to an expansion of ECS and an increase in the volume fraction. As noted
in studies conducted by Haar, this condition would lead to an increase in the amount of
available space for the infused medication to occupy.3 Therefore, it will be likely that when
equal volumes of infusate are applied to a normal brain and one suffering from VE, the

edematous brain tissue exhibits lower tissue distribution volume and higher tissue
concentration of infusate (Figure 1-2 B ) . ~
The intracellular swelling seen in CE causes a reduction in ECS and decrease in
volume fraction. Haar expected that the Gd-DTPA infusate would expand to a higher
tissue volume with lower tissue concentration given less ECS to occupy (Figure 1-2 C).
This hypothesis was successfully proved correct via e ~ ~ e r i m e n t a t i o n . ~
To investigate CED in different types of edema, Haar utilized rat brains to model
conditions of VE via direct interparenchymal albumin infusion, and CE via the middle
cerebral artery (MCA) occlusion model.3 Gadolinium-diethylene-triamine penta-acetic acid
(Gd-DTPA) was used as a model therapeutic agent for CED. Haar found, as expected, CE
led to a significantly higher volume of agent distribution with lower tissue concentrations
of infusate when compared to normal brain tissue (Figure I - ~ c ) .However,
~
the volume of
distribution and tissue concentration of Gd-DTPA did not change as expected in the VE
model. In fact, the changes followed a similar pattern as seen in CE, although they were
not significantly different from normal brain tissue and substantial variability in the data
was noted. Haar cited the possibility that the needle used to infuse albumin 24 hours prior
to Gd-DTPA infusion may have promoted "escape" of infusate along this track and might
have acted as a stab wound, which could have led to CE development.
Haar also noted a high degree of variance in the results. These were statistically
different and attributed to either of two observed scenarios: ( I ) the infusate quickly
diffused to a large tissue volume, or (2) a rapid retrograde flow of infusate. Haar explained

Figure 1-2. Diagram illustrating infusion under conditions of vasogenic and cytotoxic
edema. A: Diagram of infusion in normal brain. B: Diagram of possible infusion in brain
tissue with vasogenic edema in which the increased extracellular space creates a smaller
volume of infusion, thereby decreasing the tissue infusate concentration. C: Diagram
illustrating infusion in brain tissue with cytotoxic edema in which the decreased
extracellular space creates a larger volume of infusion and effectively decreases tissue
infusate concentrations. (Diagrams courtesy of P. ~ a a r ~ )
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the latter scenario as possibly due to back flow up a fluid channel around the cannula tract
so that it collected in the corpus c a l l o ~ u mHaar's
.~
results suggest that VE can cause either
increased interstitial pressure in the ECS thereby forcing the infusate back up the cannula
tract, or existing edematous conditions weakens the seal between the infusion cannula and
surrounding tissue to allow ba~kflow.~
The VE model utilized in Haar's experiment presented some limitations that may
have confounded the inconclusive results. These limitations were stated by the author as
the small brain size, crossing of both albumin and Gd-DTPA infusion tracts and proximity
of the infusion cannula to white matter. Due to these limitations and the invasive nature
of the model, albumin infusion presents itself as an impractical and incompatible model for
studying CED in the rat brain. Therefore, a better model of VE is needed in order to study
CED in VE. The goal of the present study was to analyze an alternative model of VE in
rodent brain that would be less intrusive and provide a consistent region of edema
development in order to study its effects on CED.

CHAPTER 2

VASOGENIC EDEMA AND THE BLOOD-BRAIN BARRIER
Pathological brain states such as traumatic brain injury (TBI), stroke, and tumors
can produce different types of brain edema.' CE results from hypoxic conditions in
ischemic areas of the brain. Specifically, a breakdown in ion transport across the cell
membranes leads to a build-up of ions within the cells. As water migrates into the
intracellular environment, there is a marked degree of astrocytic and neuronal swelling.32-34
Under conditions of CE, the cells swell as water accumulates inside of them. This
expansion of intracellular space can lead to a subsequent 75% contraction of ECS."'~~
This
change in ECS is depicted schematically in Figure 1-1C.
VE is commonly found in patients who suffer from intracranial tumors, severe head
injury, cerebral ischemia, hemorrhagic stroke and CNS infectiom2 These conditions can
lead to a breakdown in the BBB thereby increasing the permeability of local microvessels.
The BBB protects the brain and maintains homeostasis in the brain. Disruption of the BBB
results in a leakage of serum components into the parenchyma. This plasma leakage is due
to the inherent pressure gradient between the vascular space and E C S . ~The protein-rich
fluid spreads by bulk flow and by accumulating into the extracellular compartment of the
brain, can lead to cerebral swelling, compression and displacement of the brain stem,

increased intracranial pressure (ICP), systemic hypertension and cardio respiratory
collapse.2;37.38 The presence of serum water and oncotically active serum proteins results in
an expansion of the ECS. The ECS expansion has been demonstrated to lead to a volume
fraction increase from 0.19 in normal brain to 0 . 3 0 . ~
The
~ change in ECS is depicted
schematically in Figure 1-1 B.
The leaky nature of microvasculature found near tumors may be mainly attributed
to abnormalities in tight junctions found between cerebral endothelial cells. Tight junctions
are important in maintaining BBB integrity and therefore a disturbance to their structure
could lead to conditions of VE. Studies suggest that tumors lead to a deregulation of
proteins associated with maintaining the BBB. Liebner et al. found a loss of claudin-1
expression in the microvasculature in glioblastoma multiforme and a significant downregulation of the claudin-5 and occludin tight junctional proteins.39Another study also
found abnormal expression in occludin associated with tumors.40
As stated earlier, BBB integrity is necessary for keeping homeostasis in the brain.
In order to study models of VE, it is crucial to understand BBB morphology and how it can
be disrupted. These topics are discussed below.

The Blood-Brain Barrier
The brain is separated from systemic circulation by the BBB, which has both a
protective and a regulatory role. The BBB is formed by the tight junctions of the
endothelial cells that line blood vessels and the astrocytic end feet which surround them.41
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Astrocytic end feet processes ensheath the microvasculature of the brain and help maintain
the BBB by providing protection against hypoxia and aglycemia." Figure 2-1 illustrates
differences between capillaries in the brain versus systemic capillaries. Unlike systemic
capillaries, those in the brain lack fenestra, intercellular clefts, and pinocytic vesicles. 8:41
Furthermore, cerebral endothelial cells contain more mitochondria than non-cerebral
endothelial cells, roughly 3-5 times as much,8 which are needed by the multiple energydependent transporters in the BBB. In addition to the anatomical barrier created by tight
junctions, studies using iron oxide nanoparticle delivery across the BBB have suggested a
barrier at the level of the basal lamina. 21
The BBB maintains homeostasis by selectively transporting nutrients into the brain
via several transport mechanisms and structures, including endocytosis, paracellular
diffusion, transcellular diffusion, cation channels, ion antiports, and ion symports."'
Receptor mediated endocytosis plays an important role in transporting important molecules
such as iron and insulin, while 02, C 0 2 and lipophilic substances are transported via
transcellular diffusion." Generally, lipid solubility is the most important factor for a
compound to cross the B B B . ~
The major component of the BBB is the tight junction structure between vascular
endothelial cells. The junctional complex between endothelial cells is comprised of tight
and adherens junctions; tight junctions being the most apical element." Tight junctions are
crucial in maintaining the BBB by limiting the paracellular diffusion of molecules and
inhibiting build up of extracellular f l ~ i d . ~Located
'
in the cholesterol-rich region of the
Figure 2-1: Diagram illustrating differences between cerebral and systemic capillaries. A:

Cerebral capillary endothelial cells are sealed together by tight junctions and are
surrounded by glial foot processes; this structure forms the blood-brain barrier. B:
Systemic capillaries have pinocytic vesicles, fenestrations and intercellular clefts, which
are not seen in cerebral capillaries. They also exhibit a lower number of mitochondria than
cerebral endothelial cells. (Sketch based on diagram by Engelhard and ~ r o o t h u i s ~ ~ )

Intercellular
Cleft
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plasma membrane, they are comprised of three integral proteins: (1) claudin, which creates
the backbone of tight junctions, forniing the primary seal, (2) occludin, which confers
increased electrical resistance and decreased paracellular permeability, and (3) junctional
adhesion molecules (JAMS) which help regulate leukocyte migration across the BBB.~'In
addition, several accessory proteins are found within tight junctions and provide structural
support. These include zona occludens proteins (ZOl,Z02,Z03), AF6,7H6 and
cingulin."' These transmembrane and cytoplasmic proteins are linked to the actin-based
cytoskeleton of the endothelial cells. Actin binds to ZO proteins and studies have shown
that actin structural organization can determine tight junction integrity. Substances such as
cytokiiies, cytochalasin D and phalloidin can disrupt actin and have been shown to also
disrupt tight junction structure and f~nction."'~'
The assembly and disassembly of tight junctions are controlled by intricate
signaling cascades involving several cytoplasmic signaling proteins.41Extracellular levels
of calcium (ca2+)have been found to play an important role in determining tight junction
structure. ca2+is believed to be involved with the initial events of junctional complex
formation:'

while studies have found that if ca2+is removed from the extracellular

environment, electrical resistance across the membrane is reduced with a concurrent
increase in permeability.46
The phosphorylation of transmembrane and accessory proteins has been found to
be important in regulating tight junction structure. Studies indicate that tyrosine
phosphorylation can correlate to decreased occludin expression and increased permeability

across the endothelial cells.47As discussed before, the deregulation of these tight
junctional proteins may play a role in forming the tumor related VE.
Tight junction structure is also regulated by endogenous growth factors and
cytokines. Cytokines have been found to increase leukocyte migration," which triggers a
signal transduction cascade that can lead to junctional disorganization via breakdown of
ZOl and occludin, resulting in blood-brain barrier di~ru~tion.~"tudieshave shown that

vasoactive cytokines like TNFa, interleukin 1 P, interferon y and histamine, in addition to
vascular endothelial growth factor (VEGF) can increase membrane permeability.4930
VEGF is overexpressed in brain tumors, especially in GBM,' and is therefore another
mechanism which can lead to conditions promoting VE.

Blood-Brain Barrier Disruption and Clinical Applications
Although protecting the brain from harmful toxins that may appear in systemic
circulation, the BBB does pose a hurdle for delivery of drugs to help pathological brain
states. As discussed above, systemically delivered drugs must overcome issues of
appropriate size, lipid solubility and charge in order to cross into the brain." In fact, the
BBB blocks delivery of over 98% of all drugs.jl
In order to enhance drug delivery to the brain, techniques in disrupting the BBB
have been explored. Research has shown that bradykinin (BK) can specifically open the
brain-tumor-barriers through a mechanism which is mediated through the B2 receptor on
the endothelial c e l ~ s .This
~ ' leads to a transient increase in intracellular ca2+levels, which
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increases nitric oxide synthase (NOS) that results in an increase in the permeability of the
microvasculature in brain tumors. 21 The increase in intracellular ca2+can alter
cytoskeletal proteins such as nonmuscle filamin that may also enhance vascular
permeability. 2 1 Understanding this receptor mechanism has led to utilizing a BK analog,

RMP-7 (Cereport) clinically as a means of delivering chemotherapeutic agents to brain
tumors. 5 1
Intra-arterial infusion of mannitol is known for its ability to temporarily open the

B B B ~and
~ ;therefore
~ ~
has been studied as a mechanism for delivery of therapeutic agents
to the

and understanding BBB physiology.54other hypertonic solutions have

been used to provide a similar BBB disruption, such as arabinose and saline; however,
1. l M (20%)-1.4M (25%) mannitol is -themost commonly used in preclinical and clinical
studies, and the most carefully evaluated and proven reversible BBB disruption m e t h ~ d . ~ '
Antineoplastic agents such as methotrexate (MTX) can be harmful in high doses delivered
systemically. Hyperosmotic substances such as mannitol are beneficial by increasing
delivery of substances like MTX, without the need of increasing the overall systemic
dose.j6 In fact, studies have shown that when chemotherapy is administered along with
osmotic opening of the BBB, there is up to a 100-fold increase in drug delivery.21
In animal studies analyzing BBB disruption, Evan's Blue (EB) dye is the most
commonly used agent to indicate osmotic barrier opening. A 2% EB solution is infused
intravenously where it tightly binds to albumin. When the dye binds to albumin, the
resulting molecule has a molecular weight of 68,500 and therefore does not cross a normal
BBB.~'EB dye can cross over the disrupted BBB in this bound state to mark extravasated
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albumin in parenchymal brain tissue, thereby acting as a qualitative indicator of BBB
disruption. 5 4 5 7
The current study relies on BBB disruption to create conditions of VE. As
discussed briefly above and thoroughly in the next chapter, hyperosmotic mannitol has
been well characterized as a BBB disrupting agent and has also been used to create VE.
We will examine methods of edema study and various models of VE in the next chapter.

CHAPTER 3

METHODS AND MODELS OF EDEMA STUDY
There are several methods for quantifying the level of edema in brain tissue. Two
classical techniques are wet weightldry

and gravimetric analysis.60-63These

techniques are discussed below.
Wet WeightIDw Weight: In this technique, the brain tissue is extracted and
dissected in a wet or humid chamber, which ensures preservation of brain water.64 rain
areas of interest and similar size are excised from the edematous and contralateral
symmetrical gray matter.6s The brain samples are then weighed to obtain a wet weight and
then dried to a constant weight at 9 0 - 1 0 0 ~ ~ The
. ~ "dry
~ ~weight is then determined. The
percentage of water content is calculated with the following formula: % Water= (1-dry
wt/wet wt) x
Gravimetric: In this technique, the brain is removed and coronal sections are cut.
Tissue samples from the desired edematous region are dissected into pieces 1-mm3in
size.67-69
Multiple samples from a desired region are removed and placed in kerosene. A
layered kerosene-bromobenzene continuous gradient column is utilized for identifying the
specific gravity (SPGR) of each sample, and is calibrated with &SO4 samples of known
specific gravity. Each sample is placed into the top of the column and allowed to sink and
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equilibrate for a period of 1-2

minute^.^^.^' The equilibrium position of the sample within

the column is used to obtain the specific gravity of the wet tissue. These values can be
averaged over the samples from a brain region of interest and converted to water content.72
Specific gravity (SPGR) can be converted to grams of water per gram of tissue with an
established equation for rat brain The following is an example of a formula for cortical
matter in the rat brain: % H20/g tissue = (462.6lSPGR) - 362.6.73As studied by Fujiwara et
al., the specific gravity in gravimetric analysis can be affected by the following four

factors: ( I ) the purity of monobroniobenzene (MBB) and kerosene (K) and, (2) the
temperature (3) duration of interaction of MBB with tissue and/or standard solutions, and
(4) the size of tissue samples.74
Gravimetric and wetldry weight analyses are very invasive procedures that require
time and care for thorough and accurate analysis. Considering the steps these procedures
involve, there is always the possibility of some inaccuracies due to water loss in the brain
between extraction, slicing and edema measurements. The use of MRI is a non-invasive in
method that provides a high sensitivity of relaxation times of water content changes.75
Therefore, MRI is a useful tool for in vivo brain edema analysis76;77The current study will
track and analyze edema development by utilizing several MRI modalities: T2 imaging,
water maps, and ADC maps.
T2-weighted imaging is useful for identifying brain edema, due to its sensitivity to
increase in water content in the brain, and has been utilized in many edema s t ~ d i e s . ~ ~ ; ~ '
The dynamic structure and amount of brain tissue water directly influences T2 relaxation
times. 79 T2-weighted images provide a qualitative assessment of increased water content,
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which appears as hyperintense regions in the image." MRI can also be used for obtaining
quantitative data by way of ADC and water map analysis.

Water Maps: Water maps provide a quantitative assessment of the brain tissue water
content, or water fraction (f,). These water maps are generated from T1 maps, where
relaxation times are sensitive to changes in water ~ o n t e n t .Fatouros,
~'
et al. first developed
an accurate in vivo model for f, assessment based on a fast exchange two-state model,
which was validated by phantom and animal brain edema models, and later verified with
human

cLFree"bulk water in the brain exhibits long relaxation time, while

restricted ("bound") water, which is hydrogen-bonded to macromolecules in hydration
layers, has shorter relaxation times.83The longitudinal T1 relaxation time is a weighted
average between the "free" and "bound" water.84TO acquire a pure T1 image, sequential
inversion recovery images are processed, and then the T1 map points are converted to
water fraction

value^.'^ These values appear in a water map that can be analyzed by

computer software in which regions of interest (ROI) can be evaluated. Normal human
brain water was measured to range from 68% to 80% depending on the tissue type and
region.86Brain water analysis via this technique has correlated well with the gravimetric
results ( ~ ~ = 0 . 9 7 6 )thereby
,'~
validating this as an accurate and non-invasive technique.
Both T2 weighted imaging and water fraction analysis provide techniques for
identifying and measuring edema in the brain, respectively. However, for the purposes of
the current study, it is vital to be able to characterize the type of edema that is present. One
proven technique for this is ADC map analysis.

ADC Maps: ADC maps are processed from a series of diffusion-weighted images (DWI)
acquired at varying magnetic

field^.^ This imaging is sensitive to the diffusion of brain

water.88ADC values represent a quantification of water movement that can be affected by
many factors such as passive Brownian thermal diffusion, active transport, and bulk
movement.g9Water can be restricted by cell membranesg0and macromolecular binding.g'
Thus, water in both ECS and intracellular space (ICS) is subject to different types of, and
barriers to, motion.92Faster diffusing water found in the ECS would provide higher ADC
values, and therefore VE is characterized by an increase in ADC

value^.^ However, ADC

values decrease in conditions of CE, due to increased ICS water, which is less mobile, due
to interaction with intracellular macromolcules.g Using a MCA occlusion model for CE,
Ito et al., demonstrated an ADC decrease in the rat brain from baseline of 0.6 x 10"
mm2/sec to near 0.4 x

~ n r n ~ / s eUsing
c . ~ a direct infusion model of VE, ADC values

climbed to above 1.4 mm2/sec within an hour after cessation of i n f u ~ i o nExamining
.~
changes in ADC values in conjunction with T2 images provides a useful technique for
evaluating the presence of VE or CE. Studies have used this to verify the presence of
particular edema type in humans, with VE being indicated by elevated ADC and
hyperintense T2 changes.93
The aforementioned MRI modalities will be utilized in the assessment of our VE
model's characteristics and applicability to CED study. In order to select a model of VE,
published models of VE were examined for their applicability for rat brain-based CED
studies. A review of these models is presented next.

Models of Vasogenic Edema

Various animal models of VE have been used by researchers, such as albumin
injection 94,c ~ l d - i n j u r ~ ~and
" ~unsaturated
~,
fatty acid e n ~ u l s i o nand
, ~ ~intra-arterial
mannitol infusion.j5Below is a survey of some of these models and their applicability to
the current study. Some techniques discussed below were introduced in the previous
chapter's discussion of BBB disruption. The current study was in need of a rat-based
model that would demonstrate repeatable conditions of VE in brain regions applicable for
Gd-DTPA infusion and homogenous distribution such as deep gray striatum or cortical
gray region of the forebrain.

Infusion VE Model
While a number of models of this type of ECS alteration have been developed, one
of the simplest and most reliable is the infusion of a solution of normal saline containing
serum albumin.98-102 This infusion model involves intraparenchynial infusion of albumin
mixed with mock CSF via a stereotactically placed cannula into the area of interest such as
white matter or striatum.lo3This results in expansion of the ECS in a manner analogous to
that seen in human brain,'04 which reaches a maximum over approximately 24 hours, and
can persist for multiple days before

The infusion edema model for VE

shows increased water diffusion in the ECS as evidenced by hyperintense regions on ADC
maps;

Ito et al. demonstrated that ADC values increase within an hour of i n f u ~ i o n . ~

Studies conducted by Haar et al. utilized this model to investigate CED under
conditions of V E . ~
His study involved direct infusion of albumin into parenchymal tissue
along a tract made lmm anterior to the subsequent site for the infusion cannula tract. GdDTPA was utilized as a model therapeutic agent for C E D . ~As mentioned in the first
chapter, these studies proved inconclusive for studying VE in the rat brain. Reasons for
this were listed as primarily due to the invasive nature of the model possibly creating some
CE, the small size of the brain and additional factors such as tissue impedance, pore fluid
pressure and the interactions between the tissue and

an nu la.^ The small size of the rat

brain meant that the Gd-DTPA cannula tract was close in proximity to the albumin
infusion tract and white matter, thereby potentially affecting the results. Since the current
study is to be conducted in the rat brain, the model for VE should be as minimally invasive
as possible with respect to the brain parenchyma, in order to study CED in tissue that has
not been altered in any way, apart from the edema itself. To avoid the experimental
limitations observed by Haar, the albumin infusion model was abandoned and other VE
models were explored for CED study.

Unsaturated Fatty Acid Model
The unsaturated fatty acid emulsion model is a novel technique which has produced

VE in the cat brain.97The fat emulsion was made via a mixture of linoleic acid or oleic
acid with saline. The fat globules formed were less than 2 times the size of red blood
cells.97This emulsion was infused cephalad into the internal carotid artery for 5 minutes at
. ~ ~model may have some potential when used for research with
a rate of 4 m ~ l m i nThis

BBB disruption. MRI studies revealed VE and reversible changes after the unsaturated
fatty acid emulsion was infused into the carotid artery. Specifically, diffusion-weighted
imaging (DWI) and subsequent ADC maps showed evidence of VE 1 hour after emulsion
infusion and no sign of cytotoxic effect.97Although this may be useful, no studies are
available to prove the effectiveness of this technique in the rat brain, nor have consistent
areas of large edematous regions in the gray matter been demonstrated.

Toxin-induced Model
Another method of inducing conditions of VE in the rat is intraperitoneal injection
of a toxin. One study has explored this model using Hooded Wistar rats injected with the

Clostridium Perfringens (CI P) type D epsilon toxin which preferentially binds to the
brain.'07 Although the mechanism that causes the VE to form is unknown, the authors used
immunocytochemistry to detect the presence of endogenous albumin.lo7They found
albumin in the walls of the cerebral microvessels as soon as 1 hour post injection, with
maximal leakage of albumin into the parenchyma occurring at 24 and 48 hours.lo7The
authors found a partial reduction in expression of endothelial barrier antigen (EBA) that
was most prominent at 24 and 48 hours post-injection of the toxin.lo7EBA is a protein with
barrier function and is specifically expressed by rat CNS endothelial cells.
Immunostaining for EBA can also be used to detect BBB disruption. lo' Although this
toxin-based model seems to produce VE conditions, the breadth of such edema
development has not been characterized or shown to be repeatable in specific regions of
the rat brain.
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Another toxin model for VE has been produced in piglets using an intrathecal
injection of bacterial lipopolysaccharide (LPS)."~Clinical conditions such as bacterial
meningitis and traumatic brain injury show an increase in BBB permeability that is
mediated by inflammatory reaction. LPS from E. coli was used to mimic such
inflammatory conditions to produce VE. The LPS was injected into the cisterna magna
while the intracranial pressure (ICP) and cerebral blood flow (CBF) were measured, along
with intracerebral microdialysis to analyze interstitial levels of glucose, pyruvate, lactate,
glutamate, glycerol and urea.''' The authors found that 4-7 hours post LPS injection, ICP
increased and reached a plateau, and CBF increased by 46%. The LPS caused a
statistically significant decrease in glucose and increase in lactatelpyruvate ratio. There
was no increase in glycerol, leading the authors to conclude that there were no biochemical
signs of cell membrane degradation or tissue damage. This model, however, has not been
tested or characterized in the rat brain, like the unsaturated fatty acid model discussed
previously.

Cold Injury Model
Another widely used model for VE is the cold-lesion or cold-injury r n ~ d e l . ' 'This
~
is conimonly created by application of a cooled metal probe to either an intact cranium or
dura. The metal probe can range from al~rninum'~'
to copper111and is cooled to
temperatures around -80°C in a mixture of dry ice and methyl butane,

112

or liquid

nitrogen.'13 It is then placed onto the dura mater over the left parietal cortex for 30 seconds
through a 5-mm-wide ~raniotorny."~
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The cold-injury produces a necrotic lesion mainly confined to the cortical gray
matter surrounded by a narrow zone of increased permeability.1'"RI

studies of the cold

injury model have shown a periphery region of VE surrounding the area of in~u1t.l'~he
resulting edema does not form from the lesion area itself since the vessels in the lesion area
are rapidly occluded by intravascular thrombosi~."~
The likely method of extravasation in
the area below the lesion is pinocytic activity as suggested by Baker et al.'18 Another study
mentions that removal of necrotic tissue will prevent formation of edema, thus suggesting
that a substance released from the necrotic tissue is a stimulus for pinocytosis. As edema
fluid spreads from this region, it moves into adjacent white matter via bulk
After cold-injury, cortical necrosis peaks after 24 hours,'20 with maximal BBB
disruption 24 hours after injury.l2l The delayed build-up of edema is attributed to oxygen
free radicals, as seen in cortical brain injury and traumatic brain injury.lZ2During this time,
the volume of the lesion can expand up to 400%, which can be attributed to the progressive
death of parenchymal tissue and is an important manifestation of secondary brain damage.
This injury is ftlrther complicated by development of VE. One study has shown that the
freeze injury induced brain edema can decrease the microcirculatory blood flow up to 50%
from baseline. This results from the narrowing of the capillaries due to compression by
swollen astrocytic processes.123The posttraumatic hemispheric swelling reaches 50% of its
maximum at 1 hour and maximum at 12 hours.
A wet-dry weight analysis of the brains post cold-injury showed a peak water value
of 79.87% after 2 hours, which then gradually decreased and fell after 32 hours to below
.the control value of 78.22 f 0.47%.lZ4~ x c e s protein
s
content in the injured hemisphere
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peaked at a value of 21.545-2.76 mglg dry weight after 8 hours. The uninjured hemisphere
was considered to have a negligible level of protein extravasation, which was by definition,
zero. 125
The cold-injury model can produce conditions of VE in a peripheral region of
injury,'26 but is not applicable for CED studies due to the shape and cortical localization of
the edema. The region of edema does not penetrate into the deeper gray matter of the brain
nor does it create an expansive volume of edema that can be used for studying Gd-DTPA
CED. The current study required the brain volume of edema to be more widespread and
larger than the planned infusate distribution. Creating a widespread region of edema
within a hemisphere is important for studying how the infusate will behave under
conditions of VE. It was also necessary to have conditions of parenchymal space
enlargement as seen in VE and not a combination of other injury as seen in cold-injury.'27
The perturbation itself may alter the tissue in an unpredictable or irreproducible manner, in
addition to the associated brain necrosis that may complicate the infusion studies. For these
reasons, the cold-injury model was not selected for the current study.

Mannitol Model
Studies have found that intracarotid injection of 25% (1.4M) mannitol can create
reversible opening of the BBB by inducing cerebrovascular dilation and osmotic cell
shrinkage of endothelial cells. This allows for the widening of the interendothelial tight
junctions to an estimated radius of 200A.21;53;128 At the subcellular level, there may be
second messenger systems (e.g. calcium influx and nitric oxide) effected by osmotic stress
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along with cytoskeletal changes, all contributing to the barrier opening." Studies have
shown that this opening is reversible, with vascular permeability returned to baseline
within 24 * 14.3 minutes.21
As mentioned in previous chapters, intra-arterial infusion of mannitol is utilized in
the clinical setting to open the BBB for drug d e 1 i ~ e r y .Mannitol
l~~
is also clinically
administered via intravenous (IV) infusion in order to lower intracranial pressure (ICP)
after development of edema. 130-133 IV delivery of mannitol can reduce ICP by acutely
lowering blood viscosity and increasing cerebral blood flow, which triggers cerebral
arterioles to undergo autoregulatory vasoconstriction.'34 a his autoregulatory mechanism
directly affects cerebral blood flow, thus controlling the volume of intracranial blood and
thereby lowering the 1 ~ p . l ~ ~
Animal researchers deliver mannitol to the brain by way of internal carotid artery
(ICA) utilizing two different catheterization techniques. Some experiments have involved
retrograde catheterization of the external carotid artery (ECA) with SP- 10 tubing to the
bifurcation of ECA and ICA with ligation of the pterygopalatine artery (PTA). 57;95;136-138
Other studies directly catheterize via the common carotid artery using PE-50 tubing while
ligating the proximal end of the external carotid and pterygopalatine arteries.57;139 Animal
subjects are anesthetized via isoflurane while the degree of BBB disruption can be
monitored by EB dye delivered via femoral vein prior to mannitol infusion.54
Kaya et al. observed the following effects after left ICA infusion of mannitol: (1)
cardiovascular depression during infusion leading to a drop in arterial blood pressure,
returning to normal values within seconds of infusion, (2) water content in the left
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hemisphere of the brain increased significantly compared to the right hemisphere within 10
minutes of infusion, and (3) BBB permeability to albumin, as seen by EB staining, was
significant in the left hemisphere.57The same study found that magnesium sulfate, when
delivered via intracarotid or intraperitonial routes, can attenuate the BBB disruption effect
of mannit01.~~
A previous study has shown that for the highest amount of BBB disruption with
reduced mortality, an optimal rate of infusion of 25% mannitol at 37OC for adult SpragueDawley rats is 0.25ml/kg/s over 30

second^.^' This rate and duration can lead to a reliable,

reversible BBB opening without an immediate or delayed neurotoxic

Studies

have found that this concentration of mannitol has shown excellent BBB disruption in 95%
of normal rats.21For a 300g rat, this amounts to a flow rate of roughly 4.5 mllmin and a
total amount of 2.25m1 of solution delivered.
Histological rat brain studies by Salahuddin et al. have shown that after one hour, a
single 1.5mL injection of 1.4M (25%) mannitol via the ICA can lead to spongy appearance
in the neuropil, perivascular swelling and collapsed, dark neurons. 136,137 These pyknotic
cells can be considered either dead or dying which will eventually be subject to
macrophage mediated rem0va1.l~~
Further investigation using electron microscopy has
yielded that the dark and shrunken neurons were collapsed and surrounded by swollen
processes which were mostly astrocytic origin.137The perivascular swelling was found to
be due to swollen astrocytic processes as well.137The spongy appearance in the neuropil
was also attributed to swollen cellular processes.137The shrunken cellular appearance was
attributed by the authors to possible C E . ' ~
However,
~
the same study does cite VE being
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0 b ~ e r v e d .Although
l~~
that study was not clear as to how VE was observed, other literature
has listed swollen astrocytic processes and perivascular end feet as indications of VE.'~'
Dilated spaces around capillaries have been observed in other VE studies.I4' These
astrocytes are believed to swell due to pinocytosis of fluid from escaped v e ~ s e 1 s . l ~ ~
As reviewed in this chapter, BBB disruption due to mannitol infusion has been
investigated in many studies;57;136:137;143 however, based on a database search, only one
study actually utilized mannitol specifically for creation VE, via multiple mannitol
infusion in the internal carotid artery of mongrel dogs.55
Based on the mannitol effects illustrated by Kaya et al.57 and previous use by
Turski et a1.,55it appeared that favorable conditions of VE could be achieved with
mannitol induced BBB disruption. Of all the researched models, mannitol delivery seems
the most applicable for infusion studies. Intra-arterial infusion of mannitol appears to have
the possibility of creating a wide-spread area of edema in the deep and cortical gray matter,
without any other complications (e.g. brain necrosis seen with the cold-injury model5').
The current study will focus on using mannitol infusion to model conditions of pure
VE in the rat brain. Although the time course of BBB disruption has been extensively
the characterization of edema in the rat brain induced by intraarterial delivery
of mannitol has not been reported. The current study will characterize the time course and
extent of edema formation in order to establish a model of VE suitable for CED studies.

CHAPTER 4

HYPOTHESIS AND SPECIFIC AIMS
In order to plan effective targeted convective drug delivery into the brain, it is
important to understand how the infusate will distribute in the pathological tissue. For
example, chemotherapeutic treatment of brain tumors requires knowledge of how the agent
infused via CED will distribute in brain tissue exhibiting VE seen in peritumoral regions.
Although CED has been characterized in normal brain and conditions of CE, there has
been little success in obtaining conclusive results under conditions of V E . ~Previous
studies conducted by Haar utilized direct parenchymal infusion of albumin to create a
model of V E . ~This model, however, proved incompatible with CED study and therefore a
new model was needed. The purpose of the current study was to modify an existing model
-

of VE in order to create conditions of VE in a consistent and reliable fashion that will
cover an area large enough to contain the volume of CED infusate.
Background research on current models of VE, as reviewed in the previous chapter,
led to the possibility of using intracarotid infusions of 25% mannitol. Utilizing the
knowledge of previous studies that employed mannitol for BBB disruption and VE
production, the current study tested different doses of mannitol to achieve optimal
conditions of VE. MRI techniques and histological examination were used to verify the
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presence of VE and characterize the time-course of edema development to determine its
applicability for future Gd-DTPA CED studies.

Hypothesis: Multiple intracarotid infusions of 25% mannitol will create reproducible
conditions of pure VE in the gray matter of a single hemisphere in the rat brain. The tissue
volume affected by VE will be larger than a planned model therapeutic CED infusate
volume and the time course of VE long enough for infusate to distrib~~te
and be measured.

Specific Aims:
1) To use multiple inhsions of mannitol to obtain reproducible and unilateral edema
for CED study in the gray matter of the rat brain.

2) To characterize the time course of edema development.
3) To verify presence of VE with T2 imaging, ADC value analysis, water maps and
histological analysis.

CHAPTER 5

METHODS
All animal experiments were approved by the Committee for the Care and Use of
Laboratory Animals at Virginia Commonwealth University. Male Sprague-Dawley rats
with an average weight of 320g were anesthetized and catheterized via the right common
carotid artery (CCA) and femoral vein. Preliminary experiments were conducted (n= 17)
in which mannitol was infused at different rates and volumes until a consistent and
unilateral edema was observed based on EB dye staining and T2-weighted MRI.
From these studies, we found that 3 infusions of 25% mannitol30 minutes apart
could possibly serve as a viable model for VE in the rat brain, which warranted further
investigation. Rats (n=l 1) received this series of mannitol infusion and after the third
infusion, MRI was conducted 30 minutes, 1 hour, 24 hours and 48 hours later. Control rats
(n=9) were left untreated and scanned. Sham operated animals (n=4) were operated and
scanned at 1 hour (n=2) and 48 hours (n=2). For histological studies, 3 rats with 3
infusions of mannitol were sacrificed 2 hours after the last infusion. Further rats were
processed for control (n=2), which were left untreated, and sham-operated animals
sacrificed 2 hours (n=l), and 48 hours (n=l) after CCA ligation. Details for the procedures,
imaging, histological processing and data analysis are discussed below.

Mannitol Infusion Model
CCA Catheterization: (Figure 5-1 A) Rats were anesthetized with 1.5% isoflurane in a 2: 1
mixture of nitrous oxide and oxygen, and rectal temperature was maintained at 37OC using
a heat pad. Through a midline neck incision, the right CCA was exposed along with the
internal carotid artery (ICA) and external carotid artery (ECA) branches. The occipital
artery was cauterized and dissected to expose the ICA branch. A 4-0 suture was used to
ligate the ECA, while a 6-0 suture was used to ligate the pterygopalatine artery (PTA)
branch of the ICA. This ligating of arterial branches ensured mannitol infusion would only
occur along the ICA into the right hemisphere of the brain. The CCA was ligated at the
proximal end and a P-50 catheter was introduced into the lumen and inserted up through
the ICA origin. The catheter was secured by tightening another 4-0 suture around the
catheterized CCA. The femoral vein was also catheterized in a similar fashion with a P-50
catheter, after ligating the distal end with a 4-0 suture.

Femoral Vein Catheterization: (Figure 5-1 B) The right femoral vein was exposed and
ligated with a 4-0 suture at the distal end. A PE-50 catheter was inserted into the right
femoral artery for either blood pressure monitoring (n=5), or EB dye delivery (n=5).

Figure 5-1. Diagram depicting catheterization of CCA and femoral vein. A: The CCA
with catheter and ligated branches (the occipital artery is cauterized). B: The femoral vein
catheterized and ligated.
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Femoral Veln
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Evan's Blue Dye: EB dye was utilized to mark BBB disruption on mannitol infused rats
(n=5), and brains were examined 2 hours (n=3) and 48 hours (n=2) after the last mannitol
infusion. EB dye (2% in saline) was delivered at 2mllkg via the catheterized femoral vein
5 minutes prior to the first mannitol infusion.

Mannitol: Mannitol(25N at 37.0+1 "C) was delivered via catheterized CCA at 2.5mllkgls
for a period of 30 seconds. In total, 3 doses of mannitol were delivered at 30-minute
intervals. After the third infusion, the catheters were removed.

Imaging: Control rats (n=9) were left untreated for imaging. For surgical control, shamoperated rats (n=4) had their right CCA sutured closed and were imaged 1 hour (n=2) or 48
hours later (n=2). Mannitol was infused in 11 rats. After the third mannitol infusion, rats
were scanned to acquire T2-weighted (T2W), diffusion-weighted (DWI), and T1 Maps
(TIM). The time interval between the infusion and imaging and rats scanned per image
type were as follows: 30 minutes (n=3 for DWI and TIM), 1 hour (n=4 for DWI and
TIM), 24 hours (n=2 for DWI, n=3 for T1M) and 48 hours (n=3 for DWI, n=4 for TIM).
Although EPI DWI imaging was used for its short acquisition time, some the same rats
(n=5) were also imaged with SE DWI for control (n=l), after 1 hour (n=2), and after 1.5
hours (n=3) of mannitol infusion. T2 images were acquired at every scan. Imaging
procedures are described below.
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Imaging placement: Each rat to be scanned was either kept under isoflurane anesthesia if
imaging was conducted on the same day as mannitol infusion, or anesthetized by
intraperitonial administration of 0.5 ml of ketamine (50mglml) for 24 and 48-hour followup. Each rat was placed in an acrylic imaging tube, secured via plastic ear bars, and fitted
with a surface coil. Images were acquired with a 2.4 T, 40-cm bore magnet (Bruker
Medical, Inc., Billerica, MA) equipped with a 12 cm inner-diameter, actively shielded
gradient insert (maximum gradient strength: 25 Glcm). An actively decoupled RF coil set
was used for RF excitation/reception and was con~prisedof a 7 cm inner-diameter
"birdcage" design resonator and a 2 cm diameter circular surface coil.

T2 images: T2-weighted images with echo time (TE) of 100 msec, and repetition time
(TR) of 3000 msec, were obtained on 7 contiguous coronal slices 2-mm thick with a
resolution of 96 by 96.

EPI DWI: DWI (TR: 1500 msecl TE: 4lmsec) images were taken which employed an echo
planar based spin echo sequence appropriately modified to include diffusion-sensitizing
gradients along the readout (horizontal) direction with a duration of 9msec and a gradient
separation of 20 msec. Each data set consisted of 5 coronal slices of the forebrain and
midbrain region, each slice being 2-mm thick with a resolution of 128 by 128 and a 30mm2 field of view. Diffusion weighting factors, or b values of 0 and 1042s/mm2 were used
(maximum gradient strength of 23 Glcm). ADC maps were processed from DWI images
using the MRVision software package (MRVision Co., Winchester, MA).

SE DWI: DWI (TR: 1500 msecl TE: 39 msec) images were taken which employed a spin
echo sequence appropriately modified to include diffusion-sensitizing gradients along the
readout (horizontal) direction with a duration of 4 msec and a gradient separation of 25
msec. Each data set consisted of 5 coronal slices of the forebrain and midbrain region,
each slice being 2-mm thick with a resolution of 128 by 128 and a 30-mm2 field of view.
Diffusion weighting factors, or b values of 4.2, 160.5, 557.6, and 1195.6 s/mm2 were used
(maximum gradient strength of 23 Glcm). ADC maps were processed from DWI images
using the MRVision software package (MRVision Co., Winchester, MA).

T1 images: Two-dimensional T1 imaging series were generated with a spin echo, echoplanar imaging sequence preceded by an inversion recovery preparation period using a
hyperbolic secant inversion pulse. T1 maps were calculated from data obtained on 4
coronal sections at a thickness of 2.5mm and slice separation of 3.0mm. Inversion
recovery times were: 30,60, 150,300, 700, 1300, and 2500 msec.

Data Analysis: Average ADC values were obtained from regions-of-interest (ROI)
outlined in the cortical and deep gray matter over four slices. Water maps were calculated
from the T1 Maps using the MRVision software. Average water fraction (f,) values are
extracted from ROIs defined in cortical and deep gray tissue structures over four slices.
Figure 5-2 provides an example of left hemisphere cortical and deep gray ROI outlines

examined on ADC and water maps, similar ROIs were used on the right hemisphere. Mean

ADC and f, values from edematous regions for each time period were compared to
contralateral and untreated brain means using t-tests and graphical analysis.

Gd-DTPA infusion
These steps were carried out to test the appearance of infusate in a selected region
of the brain such that volume of distribution would occupy edematous tissue. Utilizing T2
images from preliminary experiments, a tentative CED infusion sight located in the cortical
gray of the forebrain (4 mm anterior and 3 mm right lateral to bregma). The
macromolecular contrast agent gadolinium (Gd) chelated by diethylenetriamine pentaacetic
acid (DTPA), (Gd-DTPA), was utilized to model therapeutic agent distribution.

Guide cannula implantation: 2 rats received a fixed guide cannula 24 hours prior to
imaging as follows. Each rat was anesthetized by intraperitoneal administration of 0.5 ml
of 1:10 ketamine:xylazene mixture (both 50mglml) and positioned in a stereotactic frame.
Based on preliminary mannitol studies, a location in the right frontal cortex was decided
upon as an infusion site. An infusion burr hole was created 3 mm lateral and 4 mm anterior
to bregma. An outer guide cannula (Plastics One, Inc.; Roanoke, VA) was stereotactically
placed through the infusion burr hole and fixed to the skull and to a plastic anchor screw
using methylmethacrylate. The tip of the guide cannula was capped until infusion.

Figure 5-2. Example ROIs outlined on ADC and Water Maps. A: ROIs drawn in left
cortical and deep gray on an ADC map. B: ROIs drawn in left cortical and deep gray on a
water map.
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Contrast infusion and imaging: Rats (n=2) received identical infusions of 10.833 mM GdDTPA in mock CSF. This solution was doped with O.1lmM manganese chloride to match
the TI value of the rat caudate putamen. The rat was positioned inside an acrylic imaging
tube, secured with plastic ear bars, and fitted with the circular surface coil (Bruker,
Billerica, MA). An inner cannula was inserted into the infusion guide cannula, the rat and
entire acrylic imaging tube placed in the magnet, and 10 pl of the Gd-DTPA solution was
infused at a steady rate of 0.2 pllminute over 50 minutes, using a motor-driven syringe
(Bioanalytical Systems, Inc., West Lafayette, IN). During and following this infusion, T1
mapping data was acquired every 10 minutes for 130 minutes, resulting in 13 data sets. T1
maps were calculated from data obtained on 4 coronal sections at a thickness of 2.5mm and
slice separation of 3.0mm. Inversion recovery times were: 30, 60, 150,300, 700, 1300, and
2500 msec. Each rat was then removed from the magnet and sacrificed.

Histological Procedures
Common Preparation for Light and Electron Microscopy: Untreated, sham-operated and
mannitol-infused rats were prepared for both light (LM) and transmission electron
microscopy (TEM). 2 hours post mannitol infusion, rats were transcardially perfused via
catheter inserted into the left ventricle. First, 0.9% saline was delivered for 2-3 minutes
until the returning perfusate from the right atrium appeared cleared of blood. Next,
perfusion of fixative was initiated. Fixative was a solution of 4% paraformaldehyde and
2% glutaraldehyde in 0.1M Sorenson's phosphate buffer. A total of 500mL of fixative was
perfused through the brain. The brain was extracted and sectioned into 4 coronal slices,
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beginning from the frontal pole at the following thickness: 3mm, 2mm, 3mm, and 3mm.
The 2mm slices were processed for TEM analysis and remaining tissue was utilized for
LM processing.

Light Microscopy Preparation: Each slice for LM study was embedded in paraffin blocks.
From each block, 2 consecutive 7 pm slices were cut with a microtome. Each slice was rehydrated with graded ethanol series: loo%, 9096, and 70% for two minutes each. Next they
were stained with hematoxylin then with eosin stains. After staining, each slice was
dehydrated with graded ethanol and 2 consecutive slices from the same block were
mounted on the same slide with permount. Images were captured using the Nikon E800 M
Eclipse Microscope with SpotRT camera (Diagnostic Instruments).

Transmission Electron Microscopy Preparation: The 2-mm thick sample for EM study was
cut via vibratonie into 3 consecutive 40 pm thick slices, with remaining tissue processed
for LM study. Each slice from the sample was washed with O.1M Sorensen's phosphate
buffer at 4OC then postfixed with 1% osmium tetroxide in 0.1M phosphate buffer at 4OC
for 1 hour. Samples were then washed with buffer and dehydrated with a cold ethanol
series: 50%, 70%, 80%, and 95%, for 5 minutes each. Next, slices were dehydrated with
100% ethanol at 20°C, followed by 3 changes of 100% propylene oxide for 10 minutes
each. Slices were placed in a 1:1 propylene oxide:PolyBed solution for 4 hours, and then
transferred to pure PolyBed resin overnight. Each section was embedded on vinyl slides
and placed in a 60°C oven overnight. After LM examination, sections were chosen and
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excised from the cortical and deep gray region for remounting on blocks and further
sectioning. Using the LKB 2 120 Ultramicrotome, 9008 sections were cut with a diamond
knife. Each section was then placed on Formvar-coated slotted grids and stained with
uranyl acetate and lead citrate for TEM study. A JEOL JEM-1230 (JEOL USA, Inc.)
transmission electron microscope was used to capture images via the Ultrascan 4000
camera (Gatan, Inc.)

CHAPTER 5

RESULTS
The selected mannitol model for VE involved 3 doses of right intracarotid mannitol
infusion at a rate of 0.25mllkglsec over 30 seconds, 30 minutes apart. This model was
examined by qualitative and quantitative analysis of data obtained from MRI, gross and
histological tissue examination. Gross brain observation using EB dye was conducted to
look for evidence of BBB disruption. MRI was used to track development of edema over
'

time using water (f,) map and ADC map analysis. T2-weighted imaging provided a
qualitative understanding of edema development. Light microscopy (LM) and
transmission electron microscopy (TEM) were used to examine the treatment effect on the
tissue and support evidence of any edematous conditions discerned from MRI study. The
results from each of these analyses are described below.

Evan's Blue Dye

Brains extracted from rats after mannitol delivery clearly showed unilateral EB dye
staining in the right hemisphere. Figure 6-1 shows a representative image of the brain
upon extraction 2 hours after the 3rdmannitol infusion. All rats that had brains perfused
with mannitol into the right internal carotid artery (ICA) exhibited staining throughout the
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ipsilateral hemisphere. As seen in the coronal sections, the staining permeated through the
cortical and deep gray (caudatelputamen) matter, while the contralateral left hemisphere
remained unstained.

T2-Weighted Images
The T2W images obtained 30 minutes and 1 hour after the last mannitol infusion
displayed a consistent and marked liyperintensity through the right hemisphere, ipsilateral
to infusion. This was a uiiilateral hyperintensity that appears to occur through all of the
forebrain and midbrain cortical and majority of deep gray (caudatelputanien) regions.
Swelling was also observed within the right hemisphere, marked by a midline shift. There
was no apparent hyperintensity in the contralateral gray matter, however, the contralateral
ventricles and white matter did show some hyperintensity. Similar results were seen in the

T2W images 1 hour after the last mannitol infusion. Figure 6-2 A contains T2W images of
a sham-operated and a normal untreated control rat brain, both exhibiting uniform intensity
throughout the hemispheric gray and white matter. Figure 6-3 A and Figure 6-4 A depict
representative T2W images of a brain after 30 minutes and 1 hour, respectively, from
different animals. An untreated rat brain T2W image is included for comparison. Figure

6-5 A and Figure 6-6 A respectively depict T2W images from the same rat after 24 and 48
hours of infusion and include an untreated rat brain T2W image for comparison. T2W
images seen after 24 hours displayed a large reduction in swelling and hyperintensity when
compared to the previous day scans, with some remaining hyperintensity in the cortical
gray region of the forebrain. After 48 hours, the T2W images displayed no obvious

swelling. In addition, with the exception of some reduction in the right cortical
hyperintensity seen 24 hours prior, the right hemisphere gray matter intensity appeared to
match controls.

Water Maps
Water maps obtained 30 minutes and 1 hour after mannitol infusion displayed
hyperintensity in the right cortical and deep gray regions, ipsilateral to mannitol perfusion.
As shown in Figure 6-7, these regions appear to be analogous to hyperintensity observed
in correlate T2W images obtained from the same animal 1 hour post infusion. Water maps
obtained at later time points did not show evidence of intensity difference between the
hemispheres.
Water maps provided water fraction (f,) values that were extracted via region of
interest (ROI) analysis described in the previous chapter. Figure 6-8 contains graphs that
show changes off, values over time after mannitol infusion, for cortical, deep and average
gray matter. Values at 0 hours represent control f, values in untreated brains. Average
gray matter had a normal f, of 77.8% in the right hemisphere and 77.9% in the left (Figure
6-8 A). Within 30 minutes of mannitol infusion, averaged ipsilateral gray matter (right
hemisphere) displayed a water fraction of 83.8% versus a level of 78.3% seen in the
contralateral gray matter (left hemisphere). There was a statistically significant difference
observed between the hemispheres (p<0.05) which remained high after 1 hour, where f,
was increased to 84.8% in the right hemisphere compared to 78.3% in the left, as indicated
by the asterisks on the graph. The f, values dropped to near normal values at 24 and 48
hours, with no significant difference existing between right and left hemispheres.
A similar trend was observed when the cortical and deep gray regions were
analyzed separately. Cortical gray tissue had a normal fwof 79.3% and 79.2% in the left
and right hemispheres, respectively (Figure 6-8 B). At both 30 minutes and 1 hour, the
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right gray matter showed a higher average than the left, which was statistically significant
(p<0.05). The right cortical gray matter showed a rise in f, to 85.5% after 30 minutes and
86.3% after 1 hour. The contralateral left cortical gray matter remained at normal levels
after 30 minutes, however, increased to 8 1.O% after 1 hour. The left cortical gray average
at 1 hour produced a p-value of 0.048 using a t-test compared with the normal values (at
time 0), which suggests a statistical difference (p<0.05). The left hemisphere also showed
a difference in f, at 48 hours that was higher and statistically different from normal
(p=0.025). Right hemispheric cortical gray f, values dropped after 24 and 48 hours. Right
and left cortical gray f, values were not significantly different between each other after 24
and 48 hours; however, the right cortical gray had an elevated f, at 24 hours (80.9%) that
was statistically significant when compared to the normal right cortical value (79.2%).
Deep gray (caudatelputamen) tissue had a normal f, of 76.3% for the left and 76.7% for
the right hemisphere, which appeared to be less than the normal f, observed in cortical
regions (Figure 6-8 C). The right deep gray matter showed higher f, values after 30
minutes (82.0%) and 1 hour (83.2%) when compared to the left deep gray matter that
remained near 77%, that were statistically different (p<0.05). The right hemisphere
dropped to near normal at 24 (77.9%) and 48 hours (77.9%) with no statistically significant
difference from the left hemisphere. The left hemisphere remained near normal through the
24 and 48 hour observations with no statistically significant change from normal values as
seen in the cortical gray. Sham-operated rats displayed normal water values at 2 hours
and 48 hours post-surgery, with no statistically significant difference in the values between
the hemispheres and when compared to normal brain tissue.

Figure 6-7: Water Map image of rat brain 1 hour after the third mannitol infusion.
A: Treated brain. Note hyperintense regions in right hemisphere. B: T2 images of
corresponding slices from same treated brain.

Figure 6-8: Graph of water fraction (f,) changes in gray matter after mannitol delivery.
A: Combined cortical and deep gray matter averages over time. B: Cortical gray matter
changes over time. C: Deep gray matter (caudatelputamen) changes over time.
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Apparent Diffusion Coefficient Maps
ADC maps obtained 30 minutes and 1 hour post mannitol infusion showed some
hyperintensity in the right hemispheric cortical and deep gray regions, when compared to
the contralateral hemisphere. There is also a hyperintensity observed in the white matter
tracts through the corpus callosum. Figure 6-9 displays the ADC map obtained at the 1hour mark in the same animal whose water map is shown in Figure 6-8. This is a
representative ADC map, where hyperintense regions were not as pronounced as seen in
T2W images and water maps.
ADC ROI analysis was conducted in a manner similar to water map analysis.
Figure 6-10 contains three graphs corresponding to the average gray, cortical gray and
deep gray (caudatelputamen) ADC value changes over time. Values at 0 hour represent
control ADC values in untreated animals. Overall, the average gray matter had normal
ADC values of 0.58 x

mm2/sec in left and right hemispheres (Figure 6-10 A). After

mannitol infusion, average gray values were 0.53 x loe3mm2/sec in the left hemisphere
and 0.51 x

m 2 / s e c in the right hemisphere, 30 minutes after infusion. Afier 1 hour,

these values were 0.45 x

mm2/sec in the left hemisphere, while remaining at 0.5 1 x1 o

mm2/sec in the right hemisphere. Of note, the differences between the hemispheres were
not statistically significant at these two time points. Also, there was no statistically
significant change in average gray matter values when compared to normal brain tissue
from the 0 time measurements or from untreated control animals. After 24 hours,
hemispheric average gray matter ADC was 0.54 mm2/sec in the left hemisphere and 0.64 x
10" mm2/sec in the right hemisphere. The right hemisphere gray matter had a higher ADC

-~

Figure 6-9: ADC images of rat brain 1 hour after the third mannitol infbsion. Note
hyperintense regions in right hemisphere.

Figure 6-10. Graph of ADC changes in gray matter after mannitol delivery. A: Combined
cortical and deep gray matter averages over time. B: Cortical gray matter changes over
time. C: Deep gray matter (caudatelputamen) changes over time.
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than the left after 24 hours, and this difference was statistically significant (p<0.05). When
compared to normal tissue ADC from the 0 time measurements, each hemisphere also
showed a statistically significant difference at the 24-hour mark. After 48 hours, the
average gray matter ADC was near normal values with no statistically significant
differences observed.
When observed separately, cortical gray matter is seen to follow the same pattern as
the average gray matter values (Figure 6-10 B). The normal cortical gray matter ADC was
measured to be 0.59 x

mm2/sec in the left hemisphere and 0.57 x lo-' mm2/sec in the

right hemisphere. The left and right cortical gray matter ADC values were 0.56 x lo-'
nim2/sec and 0.52 x lo-' mm2/sec, respectively, 30 minutes after mannitol infusion. After
1 hour, the left cortical gray matter ADC value was 0.48 x lo-' mm2/sec, while the right
cortical gray matter value was 0.53 x lo-' mm2/sec. The differences between the left and
right cortical gray at 30 minutes and 1 hour were not statistically significant; nor were they
individually statistically significant in difference from normal values. After 24 hours, the
left cortical ADC value was 0.58 x 1o - mm2/sec,
~
while the right cortical ADC was higher
than normal at 0.67 x lo-' mm2/sec. The right cortical gray matter had a higher ADC from
both the normal tissue and contralateral regions that was statistically significant (p<0.05).
After 48 hours the ADC values were near normal with no statistically significant
differences.
The deep gray ADC values followed the same pattern of change observed in the
cortical and overall gray matter, with some differences (Figure 6-10 C). The normal ADC
values in the deep gray were observed to be 0.58 x

mm2/sec in the left and right deep
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gray matter. 30 minutes after mannitol infusion, the ADC values were 0.5 1 x 10" mm2/sec
and 0.48 x

mm2/sec in the left and right deep gray matter, respectively. The average

ADC in the left deep gray matter was 0.41 x 10-3mm2/sec after 1 hour, while the right
deep gray average ADC value remained at 0.48 x

mm2/sec. There was no statistically

significant difference found between the hemispheres at these time points or when
compared to normal tissue. After 24 hours, the deep gray matter ADC values were 0.53 x
loe3mm2/sec in the left hemisphere and 0.61 mm2/sec in the right hemisphere. At 24

hours, the difference observed between left and right deep gray ADC was statistically
significant (p<0.05). In addition, both right and left deep gray matter ADC values were
statistically significant in difference when compared to normal ADC values. The ADC
values in the left deep gray matter was 0.54 x 1o - mm2/sec
~
after 48 hours. This difference
from normal values was statistically significant. After 48 hours, the right deep gray ADC
returned to the normal value of 0.58 x 10" mm2/sec. Sham-operated rats displayed normal
ADC at 2 hours and 48 hours post surgery, with no statistically significant differences.
-

Light Microscopy
Brain tissue extracted from cortical and deep gray regions in control, shamoperated, and 2 hours post mannitol infusion were observed using light microscopy (LM)
under hematoxylin and eosin (H&E) staining. Cortical gray regions in the left hemisphere
contralateral to infusion (Figure 6-11) appeared to contain healthy neurons and normal
blood vessels when compared to analogous regions in untreated control animals (Figure 6-

14). In the infused brains, the right hemisphere showed marked differences in structures
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when compared to the contralateral left hemisphere. As seen in Figure 6-11 B1 and B2,
the right cortical gray regions contained perivascular spaces surrounding the overwhelming
majority of blood vessels. Also present were perineuronal spaces surrounding the majority
of neurons. The neurons themselves appeared to be shrunken and dark in the ipsilateral
perfused cortical gray matter when compared to the neurons in the contralateral
hemisphere (Figure 6-11 A1 and A2). Also observed was a spongy appearance in the
neuropil in the right cortical gray matter, which appeared more uniform and dense in the
contralateral left cortical gray region.
In Figure 6-12, similar results are shown for the deep gray matter
(caudatelputamen) of the mannitol-infused rat brain. These images are from the same rat
brain as seen in Figure 6-11. As noted earlier, the left hemisphere contralateral to
mannitol infusion (Figure 6-12 A1 and A2) appears to contain blood vessels and neurons
that are comparable to those seen in the control deep gray regions. We also see a similar
perivascular white space surrounding virtually all blood vessels in the deep gray region of
the right hemisphere (Figure 6-12 B1 and B2). The perineuronal space surrounding dark,
shrunken neurons were not as prevalent in the ipsilateral right deep gray region when
compared to the same hemisphere's cortical gray matter. The distributed bundled tracts
that appear throughout the caudate region are seen as disparate pale regions in the neuropil.
These bundles appear uniform in the contralateral deep gray matter, but take on an
irregular appearance in the ipsilateral right caudate region.
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Representative images of the cortical and deep gray regions in sham-operated rats
are shown in Figure 6-13. The blood vessels, neurons and overall neuropil appear
identical to the analogous regions in the untreated control brain shown in Figure 6-14.
Transmission Electron Microscopy
Transmission electron nlicroscopy (TEM) was performed on the right cortical gray
regions of normal rats and in cortical gray regions ipsilateral and contralateral to mannitol
infusion. Figure 6-15 depicts representative images of blood vessels and neurons in an
untreated animal and an animal sacrificed 2 hours after the third mannitol infusion (this
example is from the same rat shown in LM photographs discussed above). The
contralateral cortical gray structures (Figure 6-15 B and E) appear similar in morphology
to those found in the control cortical gray matter (Figure 6-15 C and F).
As seen under LM, there is a marked difference in morphology of the region
surrounding blood vessels and neurons in the mannitol perfused cortical gray when
compared to similar regions in the contralateral and control tissue. In perfused tissue,
perineuronal space observed in LM pictures appears to be swollen processes surrounding
the neuron as seen in Figure 6-15 A. These white areas appear to be membrane-enclosed
fluid spaces with free-floating mitochondria. The neuron in Figure 6-15 A also appears to
have a scalloped shaped due to the surrounding swollen processes. In addition, when
compared to the contralateral and normal neurons, the neuron located in the right cortical
gray appears to have a denser cytoplasm. The mitochondria inside the cytoplasm appear
similar to those in the normal and contralateral neurons. The capillary shown in Figure 6-

15 D exhibits the perivascular space observed in LM images earlier. Upon closer
examination, this space may be due to swollen astrocytic processes surrounding the blood
vessel as evidenced by membrane and mitochondria free floating in the watery spaces.
The neuropil surrounding the neuron and blood vessel in the perfused tissue
appears to be more irregular in distribution when compared to contralateral and normal
tissue. There seem to be a great deal of white spaces in this tissue that can be mostly
attributed to swollen cellular processes. Figure 6-16 contains images of neuropil
surrounding blood vessels in the mannitol-perfused and normal tissue, shown previously in
Figures 6-15 D and F, respectively. Upon closer examination of the neuropil in the

perfused hemisphere (Figure 6-16 A2) there are white areas which seem to be enclosed by
cellular process, however, some irregular white regions appear to be fluid-filled space
which may be ECS. This putative ECS seems to be undistinguishable in the denser
neuropil of normal tissue (Figure 6-16 B), which appears quite packed and dense in
appearance.

Gd-DTPA Infusion
Figure 6-17 depicts a TI -map representative of gadolinium-diethylene-triamine penta-

acetic acid (Gd-DTPA) infusion. This image shows a series quantitative T1 map images
acquired every 10 minutes during the course of a 50 minute Gd-DTPA infusion and 80
minute follow-up, 130 minutes total. Time 0 shows the normal frontal cortical gray region,
after which infusion begins as indicated. The Gd-DTPA appears as a dark region in the
right cortical gray due to the low relaxivity attributed to Gd. The Gd-DTPA appears
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to be isolated to the right cortical region throughout the infusion, and once infusion ends at
the 50-minute mark, the Gd-DTPA appears to dissipate based on the observed return to
baseline contrast.

Figure 6-17. Time series T1 Map of Gd-DTPA infusion in frontal cortical gray matter of a
normal brain. Infusion begins at time 0 and ends after 50 minutes, as indicated on the
diagram. Note infused Gd-DTPA appears as a dark region in right hemisphere due to the
decrease in T1 value caused by the Gd relaxivity effect.

CHAPTER 7

DISCUSSION
Understanding the dynamics of CED under pathological brain states is vital for
proper drug targeting and dosage. Previous studies by Haar characterized this convective
delivery in C E . ~However, CED under VE proved inconclusive due to limitations
attributed to the direct infusion VE model.3 Therefore, the current study looked to find a
better model to study CED in VE conditions.
The mannitol infusion model of VE was selected to be characterized and evaluated
for CED study. The mannitol model was modified from two infusions of 25% mannito15'
to three infusions, based on preliminary studies we conducted in rat brain, using T2W
imaging as an initial criterion for edema formation. The preliminary studies indicated a
widespread edema formation through the cortical and deep gray matter, based on
hyperintensity observed in T2W images. Consistent BBB disruption marked by EB dye
suggested that this edema was VE in nature. Further MRI studies and histological results
confirmed a unilateral widespread edema formation in gray matter ipsilateral to mannitol
perfusion. Details on the characterization of this edema and specific implications for future
study are discussed below.

Controls

The sham-operated animals did not demonstrate changes in ADC values when
compared to normal untreated brain. Upon hematoxylin and eosin (H&E) staining,
neurons and blood vessels appeared healthy in the gray matter ipsilateral to the common
carotid artery (CCA) ligation. This was expected as previous studies have shown no acute
ischemic effect from sacrificing the right CCA in a rat.'" Our light microscopy (LM)
results also suggested no ischemic injury from CCA ligation. Therefore, changes observed
in the right hemisphere ipsilateral to mannitol infusion were due to the mannitol infusion
specifically.

Collateral Effects of Mannitol Infusion

T2W imaging was utilized in preliminary experiments to gauge edema formation
and led to the selection of the current mannitol model with three infusions. Mortality was
high in our experiment, as 7 out of the 11 (64%) perfused animals appeared to lose
spontaneous breathing 2 hours post mannitol infusion. This by itself would imply a high
degree of toxicity associated with the mannitol infusions. With the marked water levels
seen with this model, it may be that our initial use of T2 changes for titrating mannitol
doses to obtain edema development may not provide conditions favorable for animal
survival.

Edema formation
The T2W hyperintensity consistently observed in the cortical and deep gray matter
was indicative of edema formation in the right hemisphere of the brain, ipsilateral to
mannitol perfusion. This initial edema formation was seen as soon as 30 minutes after the
series of mannitol infusions, and is even evident in cortical gray tissue after 24 hours.
Water maps confirmed the presence of edema with significantly higher water values
observed in the right hemisphere when compared to the left hemisphere, 30 minutes and 1
hour after mannitol delivery. Normal human gray and white matter was found to contain
69% and 80% f,, respectively.145The current study found gray matter in the rat to have a
normal average f, of 78%. At 1 hour, water values in edematous deep and cortical gray
matter demonstrated a 6% to 7% increase in water content compared to the contralateral
gray matter. Although the increase in water content in the rat brain was extensive, larger
increases have been observed in other animals and humans. Animals studies by Fatouros
et al. have observed an increase of water content from the normal 68% seen in the white

matter of cat brain to 78.6% in edematous white matter using the infusion model of V E . ' ~ ~
The magnitude of edema increase in cat white matter was larger than what we observed in
rat gray matter. Given that edematous fluid in the ECS preferentially flows in white
matter,'" this would be expected. Another study Fatouros and Marmarou found the f, for
an ROI centered on a human brain tumor to be as high as 86.7% versus 72.1% for the
contralateral ~ 0 1 . l ~ '
The water fraction (f,) measured in the averaged gray and deep gray matter
contralateral to perfusion remained near normal through all time periods. Therefore, the

observed gray matter edema was localized to the right hemisphere. When observed
separately, however, the cortical gray matter in the left hemisphere had statistically
significant high f, observed after 1 hour and 48 hours when compared to normal cortical
gray water levels. There was a small rise in brain water in the left cortical gray matter,
despite the lack of cytotoxic injury or BBB disruption as verified by EB dye studies. In
conjunction with the bilateral hyperintensity observed in T2 images, these observations
would suggest the possibility of some contralateral flow of edema fluid from the right
cortical gray matter into the left cortical gray via white matter tracts, and would need to be
verified by future investigations. Overall, based on water map and T2 analysis, a large
cortical and deep gray region of edema was created within an hour of the series of mannitol
infusions and resolved within 48 hours.
Based on the series of processed T1 maps, the Gd-DTPA appeared to occupy a
volume of distribution that was enclosed in region of frontal cortex that consistently
showed T2 hyperintensity in other animals (Figure 7-1 A and C). As seen in Figure 7-1

B and D, Haar demonstrated Gd-DTPA distribution after CED in the caudatelputamen
region of normal rat brain that appears to occupy a similar region exhibiting consistent T2
hyperintensity in our edematous animals.55Gd-DTPA distribution results seen in the
frontal cortical gray and Haar's caudate region suggest the current model can be applied to
CED studies in both areas of the brain. Since this edema was prevalent within an hour of
infusion, and nearly gone after 24 hours, CED studies using the current model could be
conducted the same day as mannitol infusion. This model proved to be appropriate for
CED study in general edematous gray matter. However, further analysis of ADC and
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histological results were then performed in order to determine whether the observed edema
demonstrated other important characteristics consistent with VE.

Characterizing the Edema
Mannitol delivery via the internal carotid artery (ICA) at the rate we used has been
shown to produce BBB disruption after just one bolus.9s This is a reversible BBB opening
that closes within a period of 30

minute^.^' We then reasoned that multiple mannitol

infusions spaced 30 minutes would create a prolonged opening of the BBB to allow flow
of proteinaceous fluid into surrounding parenchymal tissue, mimicking the pathological
state characteristic of VE. EB dye staining prevalent throughout the right hemisphere of the
brain, ipsilateral to mannitol perfusion, provided qualitative evidence confirming effective
and extensive BBB disruption. This data was combined with studies of ADC and
histological changes in order to further characterize the edema.

Apparent Diffusion Coefficient Map Analysis
Both echo planar based spin echo (EPI) and spin echo (SE) diffusion weighted
imaging (DWI) data was collected on rats, 1 hour after mannitol delivery. ADC data
generated from this data did not show differences between the two types of imaging to be
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statistically different. ADC response was therefore studied based on EPI DWI alone as it
was a faster technique and more time-points could be collected.
VE has been shown to cause an elevation in ADC values, while CE can cause a
lowering of ADC.

Therefore, we would expect to see an elevation of ADC in the

regions of observed edema in order to characterize the presence of VE. Based on our
results, the average gray matter ADC values were lower in both hemispheres during the
first hour of edema formation, although these values were not significantly different from
normal values. Because a large amount of edema was present at this time point, based on
T2 and f, analysis, we would have expected ADC values to have been affected more
significantly, and in the opposite direction than the small, non-significant decrease that was
observed. This was the first indicator that our model may have contained both CE and VE
components in the acute phase, thereby pseudonormalizing ADC values. The right
hemisphere gray matter ADC was slightly but non-significantly higher than the left
hemisphere after 1 hour and significantly so after 24 hours. At the 24-hour mark, the right
hemisphere exhibited ADC values that were statistically significantly higher than normal
tissue. This would be consistent with the presence of some VE effect in that hemisphere, in
corroboration with the hyperintensity observed in T2W images at the 24 hour time point.
Given these findings, we went on to perform histological examination of the edematous
tissue to further investigate these possibilities.

Microscopy Analysis
After light microscopy (LM) examination, there appeared to be some cytotoxic
effect observed in the edematous gray matter under H&E staining. Studies have found that
cytotoxicity is observed by shrunken neurons with perineuronal spaces:

we observed in

the edematous hemispheres 2 hours post mannitol delivery. Previous studies have also
shown similar spongy appearance in the neuropil and the appearance of shrunken neurons
after a single bolus of mannitol perfusion in the rat brain, using the same rate and dose
used in the current study.136The spongy appearance of the neuropil and perivascular spaces
seen under H&E have also been also observed in other edematous tissue where BBB
disruption occurred.142;149
Our histological studies with H&E staining drew concern for injury to cells, with
the majority of neurons in the perfused gray matter appearing as shrunken and dark in
appearance, but transmission electron microscopy (TEM) failed to show significant
evidence of injury to these shrunken neurons. The nucleus of the neurons in the edematous
tissue appeared healthy, in addition to the presence of healthy-appearing mitochondria
observed in the cytoplasm. Therefore, the neurons in the mannitol perfused-hemisphere
appear to have been in a healthy state at the moment of fixation for EM, but the presence
of swollen processes surrounding the neurons suggest the possibility that these cells could
be in a beginning phase of d e g e n e r a t i ~ n .The
' ~ ~ perineuronal space appeared to be
expanded cellular processes surrounding the neuron, and may have contributed to the
shrunken appearance of the neurons, whereby processes pushed into the cytoplasm to
create a scalloped appearance. This may have helped to account for the darker appearance

of these neurons in the paraffin embedded LM studies as the cytoplasm was being
compacted. TEM also revealed the perivascular spaces seen under H&E to be swollen
cellular processes, as opposed to expanded ECS, mostly likely belonging to astrocytes.
Swollen astrocytic processes surrounding the blood vessels indicate some BBB disruption
to have occurred'42 as was confirmed earlier by EB dye. The fluid leaking into the ECS
may have caused hypertonic conditions that could have withdrawn water from the neuron's
cytoplasm, contributing to neuronal shrinkage. The spongy appearance of the neuropil
observed in edematous regions under H&E appeared to be due to the swollen cellular
processes, in addition to putative expansion of ECS. This would indicate an increase in
both intracellular and extracellular fluid, thereby presenting the possibility of ADC effects
from the former counteracting with ADC effects from the latter. Further studies would
need to be conducted to verify that ECS expansion was indeed occurring.
EB dye in conjunction with perivascular spaces observed under LM and TEM
revealed BBB disruption, while swollen processes surrounding shrunken neurons suggest
the presence of mild neurotoxic effects. When examined with our MRI results, the edema
appears to result from some sort of combination of VE and CE in the acute phase, while
later (at 24 hours) VE appears to be a dominant portion as evidenced by raised ADC. This
argues that the edema seen is not a "pure" example of vasogenic effect, but represents a
combination of VE due to BBB disruption followed by possible cytotoxic effects.

Conclusion
Based on our results, our starting hypothesis did not prove all together true; three
infusions of 25% mannitol did not produce conditions of "pure" VE. We conclude that
there is an acute phase of extensive edema, which seems to be a mixture of CE and VE,
which have may a pseudo-normalization effect on the ADC values. The acute edema
formed within an hour after mannitol infusion was consistent and widespread throughout
the cortical and deep gray region, and had microscopic and ultrastructural features similar
to other classic studies of brain edema. We also conclude that this model is applicable for
CED study in edematous conditions, albeit not in a setting of purely VE.
The triple mannitol infusion model for edema presented and characterized in this
study provides a good starting point for further investigations that may lead to a purer
model of VE. Due to the high mortality, the current model is not robust enough to allow
for animal survival to enable studies of edema resolution and longer-term consequences of
the mannitol infusions. Therefore, f~~rther
studies will need to investigate changes in
mannitol dosage that are titrated to changes in ADC values and water content changes, and
not to T2 changes alone, as were used in the development of this initial model. Indeed,
further studies have already been initiated, in which early results demonstrate a reduced
mortality with decreased doses and volumes of mannitol infusion. These results are
promising for subsequent MRI investigations.
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